These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7539288)

  • 1. Serotonin, schizophrenia and antipsychotic drug action.
    Breier A
    Schizophr Res; 1995 Feb; 14(3):187-202. PubMed ID: 7539288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antipsychotic drugs. A review of their pharmacology and therapeutic potential.
    Kane JM
    Drugs; 1993 Oct; 46(4):585-93. PubMed ID: 7506647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A risk-benefit assessment of risperidone in schizophrenia.
    Curtis VA; Kerwin RW
    Drug Saf; 1995 Feb; 12(2):139-45. PubMed ID: 7539272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia.
    Grant S; Fitton A
    Drugs; 1994 Aug; 48(2):253-73. PubMed ID: 7527327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
    Meltzer HY; Huang M
    Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective.
    Menkes DB
    BMJ; 1993 Jul; 307(6897):200. PubMed ID: 7688254
    [No Abstract]   [Full Text] [Related]  

  • 9. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.
    Kopala L; Honer WG
    Am J Psychiatry; 1994 Nov; 151(11):1714-5. PubMed ID: 7524373
    [No Abstract]   [Full Text] [Related]  

  • 10. Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs.
    Gellman RL; Aghajanian GK
    Neuroscience; 1994 Feb; 58(3):515-25. PubMed ID: 7513386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New psychopharmacologic alternatives in treatment of schizophrenia].
    Bryois C
    Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Dickson R; Williams R; Dalby JT
    Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
    [No Abstract]   [Full Text] [Related]  

  • 13. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    Kerwin RW
    Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
    [No Abstract]   [Full Text] [Related]  

  • 14. Unexpected dystonia while changing from clozapine to risperidone.
    Radford JM; Brown TM; Borison RL
    J Clin Psychopharmacol; 1995 Jun; 15(3):225-6. PubMed ID: 7543499
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological profile of risperidone.
    Ereshefsky L; Lacombe S
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of schizophrenia: a review.
    Sigmundson HK
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.
    Leysen JE; Janssen PM; Schotte A; Luyten WH; Megens AA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S40-54. PubMed ID: 7530377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacological profile of iloperidone, a novel atypical antipsychotic agent.
    Szewczak MR; Corbett R; Rush DK; Wilmot CA; Conway PG; Strupczewski JT; Cornfeldt M
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1404-13. PubMed ID: 7562515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in antipsychotic therapy. Introduction.
    Love RC
    Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S3-4. PubMed ID: 7538436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.